APA (7th ed.) Citation

Y, M., DT, Z., V, P., M, A. M., E, K., S, K., . . . BR, R. (2024). Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. British journal of cancer, 130(9), 1463. https://doi.org/10.1038/s41416-024-02621-x

Chicago Style (17th ed.) Citation

Y, Matoba, et al. "Targeting Galectin 3 Illuminates Its Contributions to the Pathology of Uterine Serous Carcinoma." British Journal of Cancer 130, no. 9 (2024): 1463. https://doi.org/10.1038/s41416-024-02621-x.

MLA (9th ed.) Citation

Y, Matoba, et al. "Targeting Galectin 3 Illuminates Its Contributions to the Pathology of Uterine Serous Carcinoma." British Journal of Cancer, vol. 130, no. 9, 2024, p. 1463, https://doi.org/10.1038/s41416-024-02621-x.